Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P7
Near historical low
vs 5Y Ago
-4.8x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -36.62% |
| Q3 2025 | 12.20% |
| Q2 2025 | 9.81% |
| Q1 2025 | -17.84% |
| Q4 2024 | 0.64% |
| Q3 2024 | -10.02% |
| Q2 2024 | 5.33% |
| Q1 2024 | -14.33% |
| Q4 2023 | 6.26% |
| Q3 2023 | -20.43% |
| Q2 2023 | -22.63% |
| Q1 2023 | -61.55% |
| Q4 2022 | 7.05% |
| Q3 2022 | -21.27% |
| Q2 2022 | -3.89% |
| Q1 2022 | -3.37% |
| Q4 2021 | 38.54% |
| Q3 2021 | -3.72% |
| Q2 2021 | -28.10% |
| Q1 2021 | 11.00% |
| Q4 2020 | 7.56% |
| Q3 2020 | -21.28% |
| Q2 2020 | -40.13% |
| Q1 2020 | 1.75% |
| Q4 2019 | -8.73% |
| Q3 2019 | -23.84% |
| Q2 2019 | -32.50% |
| Q1 2019 | 0.00% |